Streetbeat News

Products Services

INBS

Intelligent Bio Solutions Inc. (NASDAQ:INBS) announced that UK's Robinson Brothers is using its Intelligent Fingerprinting Drug Screening System for in-house drug testing. The system offers a non-invasive, cost-effective, and flexible solution for the 24/7 chemical manufacturing operation, replacing the previous outsourced urine-based testing. The portability and ease-of-use of the system also serve as a deterrent and support the company's Drug and Alcohol Policy.

Portfolio Pulse from Benzinga Newsdesk

January 18, 2024 | 1:40 pm

BNZI

Banzai, a company that provides engagement marketing solutions, has signed a non-binding letter of intent to acquire Cliently, a lead engagement platform. The acquisition aims to integrate Cliently with Banzai's existing products to enhance their offerings.

Portfolio Pulse from Benzinga Newsdesk

January 18, 2024 | 1:33 pm

HALO

Halozyme Therapeutics, Inc. announced that argenx has received approval in Japan for VYVDURA co-formulated with Halozyme's ENHANZE technology for the treatment of generalized myasthenia gravis. This approval could potentially lead to increased revenue for Halozyme from its ENHANZE technology.

Portfolio Pulse from Benzinga Newsdesk

January 18, 2024 | 1:32 pm

AMD

MSFT

NVDA

TSLA

Jim Cramer predicts Tesla (TSLA) may be the first to fall among the 'Magnificent Seven' stocks due to CEO Elon Musk's recent comments about needing more voting control. Cramer contrasts this with his positive view on Nvidia (NVDA) and its CEO. The article also notes that tech stocks, including Nvidia, Microsoft (MSFT), and Advanced Micro Devices (AMD), have had a rocky start to the year but are favored by analysts for their AI capabilities. Tesla faces challenges with slowing EV adoption and price cuts impacting its bottom line.

Portfolio Pulse from Shanthi Rexaline

January 18, 2024 | 1:25 pm

HOTH

Hoth Therapeutics has received FDA approval to expand its HT-001 clinical trial, allowing patients to enroll at any time and regardless of failure from other therapeutics. This expansion could potentially accelerate the trial process and improve access for patients seeking new treatment options.

Portfolio Pulse from Benzinga Newsdesk

January 18, 2024 | 1:21 pm

PBLA

Panbela Therapeutics Inc. has announced the publication of a clinical study of DFMO, an investigational drug for cancer treatment, in the British Journal of Cancer. The study's findings support the potential of DFMO as a therapeutic option for patients with pancreatic cancer. This publication could positively influence the perception of Panbela's research and development efforts in the oncology field.

Portfolio Pulse from Benzinga Newsdesk

January 18, 2024 | 1:16 pm

NVEI

Nuvei Corporation (NASDAQ:NVEI) has announced a partnership with Euroairlines to process transactions and support the airline's growth. Nuvei will handle direct and indirect traffic payments for Euroairlines globally, including the launch of a new online B2B2C portal allowing direct sales of flight tickets. The partnership is expected to enhance Euroairlines' payment processing in the US, Europe, and Latin America and add new revenue streams. Nuvei's collaboration with UATP will also process indirect traffic through UATP One Merchant Services.

Portfolio Pulse from Benzinga Newsdesk

January 18, 2024 | 1:14 pm

BNRG

Brenmiller Energy Ltd. (NASDAQ:BNRG) has received a $450,000 grant from the Israel Innovation Authority for its thermal energy storage project at Wolfson Hospital in Israel. This grant complements a previously approved $3.7 million budget from the Israel Ministry of Finance. The bGen™ ZERO system by Brenmiller is expected to save Wolfson Hospital up to $1.3 million annually and reduce its carbon footprint by 3,900 tons per year. The company has also received a grant from the Israel Ministry of Environmental Protection for a project at a beverage plant owned by Tempo Beverages Ltd., a subsidiary of Heineken International B.V. Brenmiller's bGen™ ZERO system, named among TIME's Best Inventions of 2023, is designed to convert electricity into heat for industrial processes and support utility-scale renewable energy projects.

Portfolio Pulse from Benzinga Newsdesk

January 18, 2024 | 1:14 pm

F

GM

STLA

WKSP

Worksport Ltd. announced that its SOLIS Solar Cover will be available for Ford, RAM (Stellantis), and General Motors (GM) light pickup trucks. The company has placed an order for solar panels designed for the SOLIS Solar Cover, with the first shipment expected between January and February 2024. Worksport's manufacturing facility is preparing for full-scale production, and the SOLIS Solar Cover, combined with the COR Battery System, will provide off-grid power. Worksport's CEO, Steven Rossi, expressed pride in the product's upcoming market launch for these major truck brands.

Portfolio Pulse from Benzinga Newsdesk

January 18, 2024 | 1:13 pm

ARBE

Arbe Robotics Ltd. (NASDAQ:ARBE) announced significant customer orders for its radar systems through Sensrad AB, highlighting the market's recognition of Arbe's radar chipset technology. Sensrad's Hugin 4D Imaging Radar, which uses Arbe's technology and Gapwaves' waveguide antenna, is gaining traction in various industries for its advanced perception capabilities in autonomous and robotized vehicles. Orders include those from an American autonomous transportation manufacturer, a robotized outdoor power equipment pioneer, and a key player in the transportation sector, as well as several orders from Sensrad's Chinese affiliates.

Portfolio Pulse from Benzinga Newsdesk

January 18, 2024 | 1:11 pm